Log In
Print
BCIQ
Print
Print this Print this
 

Femara, letrozole

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionAromatase inhibitor
Molecular Target Aromatase
Mechanism of ActionAromatase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationBreast cancer
Indication DetailsAdjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer; First-line treatment for postmenopausal women with advanced dependent breast cancer; Treat advanced breast cancer as first-line therapy; Treat breast cancer in postmenopausal women; Treat early-stage breast cancer in post-menopausal women; Treat early-stage breast cancer in postmenopausal women; Treat metastatic hormone-sensitive breast cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today